IACM-Bulletin of 24 October 2010
- USA: South Dakota may become the 15th state in the US to legalise the medical use of cannabis in November
- News in brief
- A glimpse @ the past
USA: South Dakota may become the 15th state in the US to legalise the medical use of cannabis in November
In 2006 South Dakota was the first state in the USA where a voter's initiative for the legalisation of the medical use of cannabis was defeated. In the upcoming elections of 2 November a new referendum has a much better chance to convince the majority of the citizens of South Dakota. The new initiative was designed to address the concerns of people that cannabis may get into the hands of people who just want to use it recreationally.
If the referendum succeeds it would make South Dakota one of the states with the most restrictive laws on the use of cannabis for medicinal purposes. It would limit the access to patients with a list of specific illnesses and conditions. It requires that patients be in a "bona fide relationship" with the recommending physician and installs a state registry and identity card system. Patients would be limited to possess up to one ounce (about 28 grams) of cannabis and six plants. They would be able to designate one caregiver and each caregiver would be able to grow for no more than five patients.
(Source: Drug War Chronicle of 20 October 2010)
News in brief
Science: Hyperactivity disorder
At the Medical University of South Carolina in Charleston, USA, 38 patients with attention deficit hyperactivity disorder (ADHD) and cannabis dependence were treated either with atomoxetine or placebo for 12 weeks. Treated patients had some improvement in a scale on clinical gobal impression. There were however no effects on self-rated ADHD symptoms by patients and cannabis use. Atomoxetine is available in many countries for the treatment of ADHD. (Source: McRae-Clark AL, et al. Am J Addict 2010;19(6):481-9.)
Science: Damage of the retina in diabetes
Scientists at the Medical College of Georgia in Augusta, USA, suggested that the natural cannabinoid cannabidiol (CBD) may be a useful novel treatment option for the damage of the retina in diabetes (diabetic retinopathy). (Source: Liou G, et al. Curr Pharmacogenomics Person Med 2009;7(3):215-222.)
Science: Gateway theory
The gateway theory says that people who use cannabis are more likely to use other and stronger illegal drugs. Following 1,286 young adults researchers of the University of New Hampshire, USA, found out that "this association fades from statistical significance with adjustments for stress and life-course variables." In other words they did not find any support for the gateway theory. (Source: Van Gundy K, Rebellon CJ. J Health Soc Behav 2010;51(3):244-59.)
A glimpse @ the past
One year ago
- USA: The federal government will no longer prosecute patients who use cannabis for medicinal purposes in states where it is legal
- USA: A majority of citizens in western states support the legalization and taxation of cannabis.
Two years ago
Online Events 2020
Please find all information of IACM Online Events including free videos of the webinars here.
Conference 2022
The 12th IACM Conference on Cannabinoids in Medicine will be we be held on 20 and 21 October 2022 together with the Swiss SSCM in Basel/Switzerland.
Members only
Regular members can sign up for the new member area of the IACM to access exclusive content.
You need to become a regular member of the IACM to access the new member area.
IACM on Twitter
Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.